Survey finds 63% of military bladder cancer patients face treatment barriers

IBRX•2026-11-11

ImmunityBio released results from a national survey in which 63% of military service members and veterans with non-muscle invasive bladder cancer faced treatment barriers.

Survey finds 63% of military bladder cancer patients face treatment barriers

1. Survey findings

Related News

Safe Pro wins AI demining contract from Ukrainian Deminers Association

NeOnc secures FDA meeting on potential accelerated approval for NEO100 brain cancer therapy

Karman Space & Defense plans to attend three investor conferences

T. Rowe Price October AUM falls to $1.83 trillion

Bond projects about 50% revenue growth in 2027